 |
|
Drug-Induced Liver DiseaseA Penalty For Progress
HANS POPPER, MD;
EMANUEL RUBIN, MD;
DANIEL GARDIOL, MD;
FENTON SCHAFFNER, MD;
FIORENZO PARONETTO, MD
Arch Intern Med. 1965;115(2):128-136.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
DRUG-INDUCED hepatic injury, particularly that associated with jaundice, is becoming more frequent because of the increasing use of potent drugs. Nevertheless, its pathogenesis remains mysterious, and its classifications is difficult. Initially, drug-induced hepatic injury followed use of established hepatotoxins as exemplified by diethylene glycol, the vehicle of an early sulfonamide preparation which proved to be a fatal poison.1 Subsequently, new disease entities were recognized after patients were exposed to drugs. For instance, intrahepatic cholestasis, then called intrahepatic biliary obstruction, following the administration of organic arsenicals, was reported by Hanger and Gutman.2 This led to the appreciation of intrahepatic cholestasis caused by agents other than drugs.3 Today, however, confusion about the many hepatic changes associated with drug therapy produces apprehension on the part of the physician when prescribing which sometimes protects the patient but almost as frequently prevents beneficial treatment or causes senseless testing for hepatotoxicity. The
. . . [Full Text PDF of this Article]
Author Affiliations
NEW YORK
From the Department of Pathology, The Mount Sinai Hospital.
Footnotes
Received for publication Aug 13, 1964; accepted Aug 17.
Reprint requests to New York, NY 10029 (Dr. Popper).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
